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Abstract
Background: Endocannabinoids modulate the glutamatergic excitatory transmission by acting as retrograde messengers. 
A growing body of studies has reported that both signaling systems in the mesocorticolimbic neural circuitry are involved 
in the neurobiological mechanisms underlying drug addiction.
Methods: We investigated whether the expression of both endocannabinoid and glutamatergic systems in the prefrontal 
cortex (PFC) were altered by an acute and/or repeated cocaine administration schedule that resulted in behavioral 
sensitization. We measured the protein and mRNA expression of the main endocannabinoid metabolic enzymes and 
the cannabinoid receptor type 1 (CB1). We also analyzed the mRNA expression of relevant components of the glutamate-
signaling system, including glutamate-synthesizing enzymes, metabotropic receptors, and ionotropic receptors.
Results: Although acute cocaine (10 mg/kg) produced no significant changes in the endocannabinoid-related proteins, 
repeated cocaine administration (20 mg/kg daily) induced a pronounced increase in the CB1 receptor expression. In 
addition, acute cocaine administration (10 mg/kg) in cocaine-sensitized mice (referred to as cocaine priming) induced a 
selective increase in the endocannabinoid-degrading enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol 
lipase (MAGL). These protein changes were accompanied by an overall decrease in the ratios of endocannabinoid synthesis/
degradation, especially the N-acyl phosphatidylethanolamine phospholipase D/FAAH and diacylglycerol lipase alpha/MAGL 
ratios.Regarding mRNA expression, while acute cocaine administration produced a decrease in CB1 receptors and N-acyl 
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phosphatidylethanolamine phospholipase D, repeated cocaine treatment enhanced CB1 receptor expression. Cocaine-
sensitized mice that were administered priming injections of cocaine mainly displayed an increased FAAH expression.
These endocannabinoid changes were associated with modifications in glutamatergic transmission-related genes. An 
overall decrease was observed in the mRNA expression of the glutamate-synthesizing gene kidney-type glutaminase (KGA), 
the metabotropic glutamate receptors (mGluR3 and GluR), and subunits of NMDA ionotropic receptors (NR1, NR2A, NR2B 
and NR2C) after acute cocaine administration, while mice repeatedly exposed to cocaine only displayed an increase in 
NR2C. However, in cocaine-sensitized mice primed with cocaine, this inhibition was reversed and a strong increase was 
detected in the mGluR5, NR2 subunits, and both GluR1 and GluR3.
Conclusions: These findings indicate that cocaine sensitization is associated with an endocannabinoid downregulation and a 
hyperglutamatergic state in the PFC that, overall, contribute to an enhanced glutamatergic input into PFC-projecting areas.
Keywords: cannabinoid, cocaine, sensitization, glutamate, prefrontal cortex.
Introduction
Cocaine addiction is one of the most prevalent drug abuse dis-
orders, and understanding its neurobiology remains a challenge. 
Unveiling the mechanisms associated with cocaine-induced 
neuroadaptions might help to improve the few effective thera-
peutic options available to date. Cocaine is a psychostimulant 
that activates, among others, the mesocorticolimbic dopamin-
ergic system that projects to the nucleus accumbens (NAc) and 
the prefrontal cortex (PFC; Hearing et al., 2012). Pyramidal gluta-
matergic cells of the PFC are activated by cocaine and glutamate 
is released into projecting areas, such as the NAc. Therefore, 
these glutamatergic neurons regulate the organization of motor 
behaviors related to drug-associated responses, including loco-
motor sensitization, drug seeking, and conditioned responses 
to drug-associated stimuli (Cardinal and Everitt, 2004; Steketee 
and Kalivas, 2011). The control of the cocaine-activated gluta-
matergic output is achieved by multiple mechanisms com-
prised of gamma aminobutyric acidic neurons (Hearing et  al., 
2013) and retrograde messengers such as those belonging to the 
endocannabinoid system (Fourgeaud et al., 2004). Dysregulation 
of glutamate release–controlling mechanisms are likely part of 
the neuroadaptions that led to the enhanced behavioral output 
observed after repeated cocaine exposure (Hearing et al., 2012).
Although the role of the endocannabinoids in psychostimu-
lant addiction has been a matter of active research (Gorriti et al., 
1999; De Vries and Schoffelmeer, 2005; Maldonado et al., 2006; 
Martin et al., 2008), there are gaps in our understanding of their 
role in the PFC-NAc pathway. The endocannabinoid system is a 
modulatory system comprised of lipid mediators termed endo-
cannabinoids (e.g., anandamide and 2-arachidonoylglycerol 
[2-AG]), the cannabinoid receptors (subtype 1 [CB1] and 2 [CB2]), 
and the enzymes that synthesize (diacylglycerol lipases alpha 
and beta [DAGLα/β] and N-acyl phosphatidylethanolamine phos-
pholipase D [NAPE-PLD]) and degrade (monoacylglycerol lipase 
[MAGL] and fatty acid amide hydrolase [FAAH]) endocannabi-
noids. In the PFC-NAc pathway, endocannabinoids retrogradely 
modulate synaptic plasticity through the stimulation of presyn-
aptic cannabinoid CB1 receptors (Freund et  al., 2003; Piomelli, 
2003), which are located in both the glutamatergic and the 
gamma aminobutyric acidic axon terminals. Endocannabinoids 
are formed upon the activation of postsynaptic glutamate 
receptors, including the ionotropic glutamate receptors (AMPA), 
NMDA-type receptors, and, especially, mGluR5 metabotropic 
glutamate receptors. Therefore, the postsynaptically-produced 
endocannabinoids reach the presynaptic glutamatergic termi-
nals and inhibit the glutamate release. This retrograde endocan-
nabinoid signaling is an essential element for the establishment 
of long-term neuroadaptations to drugs such as cocaine. In fact, 
a single administration of cocaine abolished the endocannab-
inoid-mediated, retrograde long-term depression at synapses 
between the PFC and NAc (Fourgeaud et al., 2004).
In addition to the interactions described above between 
endocannabinoids and cocaine-activated glutamatergic 
release in the PFC-NAc pathway, the endocannabinoid pro-
duction is also promoted by the dopamine D2 receptor activa-
tion (Giuffrida et  al., 1999) within the dorsal striatum, where 
it is linked to the regulation of dopamine-mediated behaviors 
(Rodriguez de Fonseca et al., 1994; Martin et al., 2008), psycho-
stimulant-induced sensitization (Gorriti et  al., 1999; Corbille 
et  al., 2007; Mereu et  al., 2013), cocaine-induced conditioned 
place-preference (Chaperon et al., 1998), cocaine self-adminis-
tration and relapse (Adamczyk et al., 2009; Fattore et al., 1999; 
De Vries et  al., 2001; Soria et  al., 2005), and cocaine-induced 
conditioned locomotion (Luque-Rojas et al., 2013).
As can be deduced from these studies, the interplay between 
cortical glutamate, the ascending dopamine pathways, and endo-
cannabinoid-mediated signaling is modified by the administration 
of cocaine. One of the most consistent models for studying this 
interplay is behavioral sensitization. Classical studies (Giuffrida 
et al., 1999; Gorriti et al., 1999) establish that both the blockade and 
desensitization of CB1 receptors facilitate the actions of psycho-
stimulants, whereas recent studies (Mereu et al., 2013) have indi-
cated that the endocannabinoid signaling is activated because the 
first cocaine administration to initiate the plastic changes leads to 
the onset of behavioral sensitization. However, there are no avail-
able data where the effects of a sensitization-inducing cocaine 
administration regimen on the endocannabinoid signaling sys-
tem are linked to the hyperglutamatergic activity in the PFC. To 
this end, we investigated whether the gene and protein expres-
sion of relevant constituents of the endocannabinoid system and 
the glutamatergic signaling pathway may be altered by acute 
cocaine administration and/or following a sensitization regimen 
of cocaine administration in the PFC of mice.
Methods
Ethics Statements
The experiments and procedures were conducted under strict 
adherence to the European Directive 2010/63/EU on the protec-
tion of animals used for scientific purposes and with Spanish 
regulations (RD 53/2013 and 178/2004). All efforts were made to 
minimize unnecessary suffering. All protocols were approved 
by the Committee on Ethics of the University of Málaga and 
Hospital RU de Málaga.
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Animals and Housing
Experimental research was performed using male C57BL/6J 
mice (25 ± 5 g; Charles River Laboratories International). All ani-
mals were maintained in the Animal Resource Center at the 
University of Málaga. All animals were individually housed in 
clear plastic cages in a temperature-controlled room (22 ± 2°C) 
under a 12 h light/dark cycle (lights off at 8:00 PM). Tap water 
and standard chow pellets were freely available throughout the 
course of the experiments.
Drugs
Cocaine-HCl was obtained from Alkaliber S.A.. Cocaine was dis-
solved in saline (0.9% NaCl) and administered at doses of 10 mg/
kg (acute) and 20 mg/kg (repeated). Cocaine or vehicle (saline) 
was administered by an intraperitoneal injection in a volume of 
10 mL/kg body weight.
Apparatus and General Procedures
All experiments were carried out between 8:00 AM and 8:00 PM. 
To acclimate the animals to the test conditions, all mice were 
allowed to rest in the testing room for 30 min prior to perfo-
ming any behavioral assessment in the open field test during 
the cocaine sensitization paradigm. Performance in the open 
field test was recorded by computer-based video tracking sys-
tem (Smart v2.5®, Panlab). The maximum light intensity in the 
center of the open field was 100 lux. Four open fields (50 x 50 x 
50 cm, Panlab) with grey backgrounds were used. The animals 
were placed in the center of the arena and their behavior was 
recorded for 30 min. Horizontal locomotion was measured as the 
total distance traveled in cm.
Acquisition and Expression of Cocaine-Induced 
Sensitization
Cocaine sensitization was conducted as previously described 
(Blanco et al., 2012) following a consecutive 5-phase paradigm 
(Figure  1A): (1) handling: all animals were handled for 10 min 
and weighed during 2 days for habituation (days 1 and 2) in the 
testing room; (2) cocaine conditioning: as commented, the mice 
were acclimated to the testing room for 30 min prior to adminis-
tration of vehicle (saline, intraperitoneally) or cocaine injection 
(20 mg/kg, intraperitoneally, once daily for 5 consecutive days, 
days 3 to 7) and were tested in the open field immediately after 
each injection; (3) resting: during the next 5 days (days 8 to 12), 
the animals rested from the open field and the drug; (4) cocaine-
conditioned locomotion: we evaluated the locomotor activity 
response induced by association between repeated administra-
tion of cocaine and the open field test using a simulated injec-
tion with vehicle (day 13); and (5) cocaine-induced sensitization: 
on the last day (day 14), the presence of cocaine sensitization 
was achieved by an acute administration of cocaine (10 mg/kg) 
that was used as the priming dose.
All animals were evaluated in the open field test to measure 
the distance traveled for 30 min using a video tracking system, 
except in the drug-free period. The experimental groups were 
(n = 8 per group): (1) repeated vehicle pretreatment and acute 
Figure 1. Acute and repeated cocaine injections on cocaine-induced sensitization in mice. (A) Schematic representation of the 5-phase-paradigm for acquisition and 
expression of cocaine-induced sensitization. (B) Effects of acute and repeated cocaine injections on the distance traveled by mice for 30 min measured in the open 
field during cocaine sensitization. Bars represent the mean + SEM (n = 8 animals per group). Post hoc analysis: *p < 0.001 versus the vehicle-vehicle group; #p < 0.001 
versus the vehicle-cocaine group; $p < 0.001 versus the cocaine-vehicle group. OF: open field; CL: cocaine-conditioned locomotion; CS: cocaine-induced sensitization.
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vehicle treatment (vehicle-vehicle group); (2) repeated vehicle 
pretreatment and acute cocaine (10 mg/kg) treatment (vehicle-
cocaine group); (3) repeated cocaine pretreatment (20 mg/kg) 
for 5 days and acute vehicle treatment (cocaine-vehicle group); 
and (4) repeated cocaine pretreatment and acute (in this case, 
the priming injection) cocaine (10 mg/kg) treatment (cocaine-
cocaine group). The animals in these 4 groups were tested in the 
behavioral studies and their brains were collected and used for 
biochemical determinations.
Tissue collection
One hour after we performed acute treatment of mice who had 
already been pretreated repeatedly with cocaine or vehicle, 
all animals were euthanized by decapitation, and their brains 
were immediately dissected out, frozen on dry ice, and stored 
at -80ºC. The brains were dissected in coronal brain slice sec-
tions (1 mm thick) on dry ice using razor blades and a mouse 
brain slicer matrix (Zivic Instruments). The PFC was precisely 
removed with fine surgical instruments (Paxinos and Franklin, 
2004). The samples were stored at -80ºC until further use for 
gene and protein analyses.
Western Blot Analysis
Western blotting was used to measure the protein levels of the 
endocannabinoid signaling system (cannabinoid CB1 receptor, 
NAPE-PLD, DAGLα/β, MAGL, and FAAH) in the PFC, as previously 
described (Suarez et al., 2008). The samples were homogenized 
in 50 mM Hepes buffer (pH 8) and 0.32 M sucrose buffer to obtain 
the membrane protein extracts. For immunoblotting, the pro-
tein samples (40 μg) were separated on 10% (w/v) SDS-PAGE gels, 
transferred to nitrocellulose membranes (BioRad) and controlled 
by Ponceau Red staining. After blocking with 5% (w/v) bovine 
serum albumin in 0.1% Tween 20 in PBS at room temperature 
for 1 h, the membranes were incubated with the primary anti-
bodies overnight at 4ºC, as described previously (Suarez et al., 
2008). The specific protein bands were visualized and quanti-
fied by chemiluminescence using an imaging AutoChemiTM UVP 
BioImaging System (LTF Labortechnik). β-actin was quantified 
and used as a loading control (anti-β-actin diluted 1:1000 from 
Sigma-Aldrich Co., cat. no. A5316).
RNA Isolation and Quantitative Polymerase chain Analysis
Real-time quantitative polymerase chain reaction was used 
to measure the relative quantification of the mRNA levels of 
the relevant receptors and synthesis/degradation enzymes 
involved in endocannabinoid signaling (CB1 receptor, NAPE-
PLD, DAGLα/β, MAGL, and FAAH) and glutamatergic signaling 
(liver-type [LGA] and kidney-type [KGA] isoforms of glutami-
nase, mGluR3/5 metabotropic receptors, and subunits of NMDA 
ionotropic receptors [NR1/2A/2B/2C-NMDA and GluR1/2/3/4-
AMPA]) in the PFC. Total mRNA was isolated using the Trizol® 
method, according to the manufacturer’s instruction (Gibco 
BRL Life Technologies). Details on the RNA extraction and cDNA 
synthesis have been previously described (Blanco et al., 2012). 
The resultant cDNAs were used as templates for the real-time 
quantitative polymerase chain reaction with an iCycler system 
(BioRad) using the Quanti-Test SYBR Green PCR kit (Qiagen). 
The primers used are described in the supplementary Table S1. 
Oligonucleotides were provided by Sigma-Proligo.
Quantification was performed according to standard curves 
run simultaneously as the samples with each reaction run in 
duplicate, as previously described (Blanco et al., 2012). The abso-
lute values from each sample were normalized with regard to 
β-actin mRNA (a housekeeping gene), which was used as a refer-
ence standard.
Statistical Analysis
Data are expressed as the mean ± standard error of the mean 
(SEM) of 8 determinations (animals) per experimental group. 
Statistical analyses of the behavioral data in studies with acute 
and repeated treatments were performed using (1) a two-way 
analysis of variance (ANOVA), with repeated pretreatment (con-
ditioning with cocaine or vehicle for 5  days) and acute treat-
ment (cocaine or vehicle) as the two factors and (2) multiple 
post hoc comparisons (Bonferroni test). P < 0.05 was considered 
significant.
Results
Cocaine Administration on the Acquisition and 
Expression of Sensitization
As shown in Figure 1A, cocaine sensitization was conducted fol-
lowing a consecutive 5-phase paradigm that was described pre-
viously. During the cocaine conditioning, the locomotor activity 
was evaluated daily in mice pretreated with repeated injections 
of vehicle or cocaine (20 mg/kg). After resting, the mice were 
injected with an acute dose of vehicle or cocaine (10 mg/kg), and 
the locomotor activity was assessed in the open field (Figure 1B). 
A  two-way ANOVA revealed that the distance traveled in the 
open field was significantly affected by the repeated pretreat-
ment (F1,28 = 26.87, p <0.0001) and the acute treatment (F1,28 = 37.89, 
p < 0.0001). Furthermore, a significant interaction between both 
repeated cocaine pretreatment and acute treatment was also 
detected (F1,28 = 10.12, p = 0.0036). A post hoc comparison between 
the paired groups was subsequently performed. The vehicle-
cocaine group displayed a significant increase in locomotion 
(p < 0.001) compared with the vehicle-vehicle group. Similarly, 
we observed that the cocaine-cocaine group displayed higher 
locomotion compared with the cocaine-vehicle mice (p < 0.001). 
Both repeated groups pretreated with cocaine—the cocaine-
vehicle group and the cocaine-cocaine group—displayed a 
significant increase in locomotion compared with the vehicle-
vehicle group (p < 0.001), which was used as a baseline for loco-
motor activity. Interestingly, repeated cocaine-conditioned mice 
that received cocaine priming (cocaine-cocaine group) showed 
a higher increase in the locomotor activity compared with the 
vehicle-cocaine group (p < 0.001).
Changes in the Endocannabinoid Signaling System 
During Cocaine-Induced Sensitization
To address whether cocaine treatment was associated with 
alterations in the endocannabinoid system, we analyzed protein 
and mRNA levels of the different components of this system 
in the PFC (CB1 receptor, endocannabinoid synthesis enzymes 
NAPE-PLD and DAGLα/β, and degradative enzymes FAAH and 
MAGL). A summary of these results can be found in Table S2.
Expression of Proteins Associated with the Endocannabinoid 
System
Western blot analysis showed that the antibodies used against 
the components of the endocannabinoid signaling system iden-
tified bands with the expected molecular weight in the PFC 
(Figure 2A), as previously described (Suarez et al., 2008; Marquez 
et  al., 2009). Thus, CB1 receptor immunoblotting revealed a 
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prominent band at approximately 60 kD, NAPE-PLD at 46 kD, 
FAAH at 63 kD, DAGLα at 120 kD, DAGLβ at 76 kD, and MAGL at 
35–37 kD.
Two-way ANOVA analyses of the protein expressions were 
performed using the repeated pretreatment and acute treat-
ment as factors. Thus, the repeated pretreatment (with vehicle 
or cocaine) had a significant effect on the protein expression of 
CB1 receptor (F1,28 = 9.15, p = 0.01) and FAAH (F1,28 = 6.94, p = 0.021), 
whereas the acute treatment only significantly affected the 
expression of MAGL (F1,28  =  12.52, p  =  0.004). No interaction 
between the factors was detected for these proteins.
Bonferroni post hoc tests showed the protein expression 
in the cannabinoid CB1 receptor was significantly increased in 
both groups pretreated with cocaine (the cocaine-vehicle and 
cocaine-cocaine groups) in comparison with the vehicle-vehicle 
group (p < 0.05). The CB1 receptor expression was also signifi-
cantly enhanced in the cocaine-cocaine mice compared with the 
vehicle-cocaine mice (p < 0.05; Figure 2B). The protein expres-
sion of NAPE-PLD was unaltered when paired comparisons were 
performed between the groups with repeated pretreatment 
and acute treatment (Figure  2C). When the FAAH expression 
was analyzed, only a significant increase was observed in the 
cocaine-cocaine group compared with the vehicle-vehicle group 
(p < 0.05; Figure 2D). No changes were detected in the expres-
sion of the DAGLα/β proteins (Figure 2E and F). Finally, the MAGL 
expression was only affected by the administration of cocaine 
priming in repeated cocaine-conditioned animals (the cocaine-
cocaine group) that displayed a significant increase in MAGL in 
comparison with the vehicle-vehicle mice and the cocaine-vehi-
cle group (p < 0.05; Figure 2G).
We also calculated the ratios of the protein expressions in the 
PFC between NAPE-PLD and FAAH (Figure 2H), between DAGLα 
and MAGL (Figure 2I), and between DAGLβ and MAGL (Figure 2J), 
because these ratios could suggest changes in anandamide 
and 2-AG production. Two-way ANOVA analyses for these three 
ratios revealed that only the DAGLα/MAGL ratio was signifi-
cantly affected by the acute treatment (F1,28  =  15.2, p  =  0.002). 
In comparison with the vehicle-vehicle group, post hoc tests 
showed that an acute injection of cocaine in both the vehicle-
cocaine mice and the cocaine-cocaine mice induced a signifi-
cant decrease in the protein expression of NAPE-PLD/FAAH (p < 
0.05) and DAGLα/MAGL (p < 0.01 and p < 0.05, respectively) ratios, 
but not for the DAGLβ/MAGL ratio, which had a non-significant 
decrease. However, the cocaine-cocaine mice displayed signifi-
cantly lower DAGLα/MAGL and DAGLα/β/MAGL ratios compared 
with the cocaine-vehicle mice (p < 0.05).
changes in the Expression of Genes Associated with the 
Endocannabinoid System
The mRNA levels of the endocannabinoid-related genes were 
also assessed in the PFC (Figure  3). Two-way ANOVA analysis 
showed significant effects of the repeated pretreatment (with 
vehicle or cocaine) on the gene expression of endocannabi-
noid elements, specifically in the CB1 receptor (Cnr1, F1,28 = 9.79, 
p = 0.0041), NAPE-PLD (Napepld, F1,28 = 5.07, p = 0.032), FAAH (Faah, 
F1,28  =  5.13, p  =  0.031), and DAGLβ (Daglb, F1,28  =  7.50, p  =  0.01). 
Figure 2. Effects of cocaine-induced sensitization on the expression of endocannabinoid signaling-related proteins in the mouse PFC. (A) Representative immunoblots 
of endocannabinoid signaling-related proteins after repeated pretreatment (vehicle or cocaine) and acute treatment (vehicle or cocaine). Relative protein levels: (B) 
CB1 receptor; (C) NAPE-PLD; D) FAAH; (E) DAGLα; (F) DAGLβ; and (G) MAGL. Ratios between the synthesis and degradation enzymes: (H) NAPE-PLD/FAAH; (I) DAGLα/
MAGL; and (J) DAGLβ/MAGL. Bars represent the mean + SEM (n = 8). Two-way ANOVA: &p < 0.05 and &&p < 0.01. Post hoc analysis: *p < 0.05 and **p < 0.01 versus the 
vehicle-vehicle group; #p < 0.05 versus the vehicle-cocaine group; $p < 0.05 versus the cocaine-vehicle group. V-V: vehicle-vehicle group; V-C: vehicle-cocaine group; C-V: 
cocaine-vehicle group; C-C: cocaine-cocaine group; ns: non-significant.
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However, the acute treatment did not produce significant effects 
in the mRNA of these cannabinoid components. The interac-
tion between the factors was detected for the FAAH expression 
(F1,28 = 5.94, p = 0.021).
Bonferroni post hoc tests showed the acute cocaine admin-
istration (the vehicle-cocaine group) showed a significant 
decrease in the mRNA levels of CB1 receptor and NAPE-PLD 
(p  <  0.05; Figure  3A and B) compared with the vehicle-vehicle 
group. The pretreatment with repeated cocaine and acute vehi-
cle (the cocaine-vehicle group) induced higher mRNA levels of 
CB1 receptor compared with the vehicle-cocaine group (p < 0.05; 
Figure  3A). The cocaine sensitization induced by the cocaine 
priming after repeated cocaine pretreatment (the cocaine-
cocaine group) produced increased levels of CB1 receptor, NAPE-
PLD, and FAAH mRNA (p < 0.01, p < 0.05, and p < 0.01, respectively) 
compared with the vehicle-cocaine group (Figure 3A–C). In addi-
tion, the mRNA levels of FAAH increased in comparison with the 
vehicle-vehicle group (p  < 0.05) and the cocaine-vehicle group 
(p  <  0.05; Figure  3C). No changes were detected in the mRNA 
levels of DAGLα, DAGLβ, and MAGL (Figure 3D–F) when the four 
experimental groups were compared.
Changes in the Expression of Genes During Cocaine-
Induced Sensitization
To address whether the cocaine behavior-related changes 
observed in the endocannabinoid signaling components were 
associated with an alteration in the glutamatergic state, we 
analyzed the mRNA expression of glutamate-synthesizing 
genes LGA (Gls2) and KGA (Gls), mGluR3/5 (Gmr3/5) metabo-
tropic receptors, and NR1/2A/2B/2C-NMDA (Grin1/2a/2b/2c) and 
GluR1/2/3/4-AMPA (Gria1/2/3/4) ionotropic receptor subunits in 
the PFC of acute versus repeated cocaine-exposed mice. The 
results are summarized in Table S3.
changes in the Expression of Genes Associated with the 
Glutamatergic Signaling System
In the PFC (Figure 4), two-way ANOVA analyses showed signifi-
cant effects of the repeated pretreatment on the gene expres-
sion of NR1 (F1,28 = 8.25, p = 0.0077), NR2B (F1,28 = 5.51, p = 0.026), 
NR2C (F1,28 = 12.57, p = 0.0014), GluR2 (F1,28 = 6.76, p = 0.014), GluR3 
(F1,28 = 6.9, p = 0.013), and GluR4 (F1,28 = 7.38, p = 0.011). Acute treat-
ment produced no effects on these glutamate components, but a 
significant interaction between both factors—the repeated pre-
treatment x the acute treatment—was observed in the mRNA 
levels of mGluR5 (F1,28 = 5.36, p = 0.028), NR1 (F1,28 = 5.15, p = 0.031), 
NR2A (F1,28  =  5.44, p  =  0.027), NR2B (F1,28  =  7.8, p  =  0.0093), and 
NR2C (F1,28 = 4.27, p = 0.048). The interaction indicated that the 
acute treatment of the cocaine priming or vehicle affected the 
gene expression of mGluR5, NR1, NR2A, NR2B, and NR2C in an 
opposite manner (increase or decrease) according to the type of 
repeated pretreatment.
Bonferroni post hoc tests showed that repeated cocaine-
conditioned animals that received cocaine (cocaine-cocaine 
group) displayed a significant increase in the mRNA level of 
LGA mRNA (p < 0.05) compared with the vehicle-vehicle group 
(Figure  4A). The vehicle-cocaine group displayed a significant 
decrease in the gene expression of KGA and mGluR3 in com-
parison with the vehicle-vehicle mice (p < 0.05; Figure 4B and 
C). The cocaine-cocaine group displayed a significant increase 
in the mRNA expression of mGluR5 compared with the vehicle-
cocaine mice (p < 0.05; Figure  4D). An acute cocaine injection 
in the vehicle-cocaine mice produced a significant decrease 
in the gene expression of NR1 (p < 0.01), NR2A (p < 0.05), NR2B 
(p < 0.01), and NR2C (p < 0.01) in relation to the vehicle-vehicle 
mice (Figure 4E–H). The mRNA levels of NR2A (p < 0.05), NR2B 
(p < 0.01), and NR2C (p < 0.01) were also significantly enhanced 
in the cocaine-cocaine mice compared with the vehicle-cocaine 
mice. In addition, the repeated cocaine-conditioned animals 
that received vehicle (the cocaine-vehicle group) displayed a 
significant increase in the NR2C gene expression in comparison 
with the vehicle-vehicle mice and the vehicle-cocaine group 
(p < 0.05 and p < 0.01, respectively). Regarding the GluR1 mRNA 
level, an acute cocaine injection in the vehicle-cocaine mice pro-
duced a significant decrease in the gene expression in relation 
to the vehicle-vehicle mice (p < 0.05). In addition, the cocaine-
pretreated group that received vehicle (the cocaine-vehicle 
group) showed a significant increase in the GluR1 mRNA level 
compared with the vehicle-cocaine group (p  <  0.05; Figure  4I). 
A  significant increase in the GluR2 mRNA level was induced 
Figure 3. Effects of cocaine-induced sensitization on the gene expression of the endocannabinoid signaling-related components in the mouse PFC. Relative mRNA 
levels of the endocannabinoid signaling system were evaluated following a repeated pretreatment (vehicle or cocaine) and acute treatment (vehicle or cocaine): (A) CB1 
receptor; (B) NAPE-PLD; (C) FAAH; (D) DAGLα; (E) DAGLβ; and (F) MAGL. Bars represent the mean + SEM (n = 8). Two-way ANOVA: &p < 0.05 and &&p < 0.01. Post hoc analy-
sis: *p < 0.05 versus the vehicle-vehicle group; #p < 0.05 and ##p < 0.01 versus the vehicle-cocaine group; $p < 0.05 versus the cocaine-vehicle group. ns: non-significant.
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in the cocaine-vehicle group in comparison with the vehicle-
cocaine group (p < 0.05; Figure 4J), while the GluR3 mRNA level 
was increased in the cocaine-cocaine group in comparison with 
the vehicle-cocaine group (p < 0.05; Figure 4K). Finally, the mRNA 
expression of GluR4 was unaltered when paired comparisons 
were performed between the groups of the repeated pretreat-
ment and the acute treatment (Figure 4L).
Discussion
The present study confirms that the endocannabinoid and glu-
tamatergic systems are modulatory systems of the neurotrans-
mission phenomena in cerebral areas involved in drug addiction 
that are susceptible to modification of their expression as the 
result of cocaine exposure. Overall, the data obtained in the 
mouse PFC suggest that during cocaine-sensitization, with a 
progressive increase in locomotor activity, the endocannabinoid 
signaling was affected; this fact could modify other signaling 
systems, including the cortical excitatory glutamatergic inputs 
in this area, given that the endocannabinoids act as retrograde 
messengers. This hypothesis is supported by previous studies 
that suggest that the first exposure to cocaine induced gluta-
mate release in the PFC-NAc pathway, followed by a depression 
of the activity of glutamate PFC neurons. Also, a progressive 
sensitization to further cocaine administrations after a period 
of chronic exposure to the psychostimulant was seen (for review 
see Hearing et al., 2012). Further, our data revealed that cocaine 
exposure also altered the gene expression of the glutamate 
signal-related components. Overall, the present results suggest 
that, after repeated exposure to a cocaine regimen leading to 
sensitization, the enhanced glutamatergic response to cocaine 
is associated with a failure in the inhibitory action of the neu-
romodulatory endocannabinoid brake. This hypothesis links 
endocannabinoid plasticity to the described adaptations of PFC 
glutamate neurons to acute or chronic cocaine exposure.
As commented, an overall decrease in the ratios of the endo-
cannabinoid synthesis/degradation was observed when the 
synthesizing-enzymes and the degrading-enzymes were meas-
ured under different behavioral paradigms of cocaine exposure, 
including both acute and repeated cocaine administration. 
We hypothesize that the reduced endocannabinoid-mediated 
inhibition might be partially responsible for the well-described 
hyperglutamatergic state associated with cocaine´s actions 
(Cornish and Kalivas, 2000). Moreover, we have observed that 
this hyperglutamatergic state was reflected in the expression 
of key signaling genes, such as glutaminases, metabotropic 
mGluR5 receptors, and AMPA-type receptor subunits. Of special 
interest is the mGLUR5 upregulation since this receptor triggers 
the formation of the retrograde endocannabinoid messenger 
2-AG, indicating the existence of dissociation between endocan-
nabinoid and glutamate cocaine-induced adaptations.
Because the PFC is involved in the control of the actions of 
psychostimulants through its projection to ventral and medio-
dorsal striatum, we suggest that the adaptations of the endo-
cannabinoid system to cocaine exposure are a relevant step 
towards the induction of plastic changes that lead to behavioral 
sensitization. Our hypothesis is that a deficit in endocannabi-
noid production could facilitate the dopamine-mediated activa-
tion of the excitatory glutamatergic transmission, which leads 
to the psychostimulant effects of cocaine exposure.
Decreased Endocannabinoid Signaling
Focusing on the endocannabinoid signaling system, we 
observed differences caused by the cocaine exposure, although 
the changes in the endocannabinoid components were more 
evident following the repeated cocaine administration, includ-
ing the cocaine-conditioned locomotion and cocaine-induced 
Figure 4. Effects of cocaine-induced sensitization on the gene expression of the 
glutamatergic signaling-related components in the mouse PFC. Relative mRNA 
levels of the glutamate signaling system were evaluated following a repeated 
pretreatment (vehicle or cocaine) and acute treatment (vehicle or cocaine): (A) 
LGA; (B) KGA; (C) mGluR3; (D) mGluR5; (E) NR1; (F) NR2A; (G) NR2B; (H) NR2C; 
(I) GluR1; (J) GluR2; (K) GluR3; and (L) GluR4. Bars represent the mean + SEM 
(n = 8). Two-way ANOVA: &p < 0.05 and &&p < 0.01. Post hoc analysis: *p < 0.05 and 
**p < 0.01 versus the vehicle-vehicle group; #p < 0.05 and ##p < 0.01 versus the 
vehicle-cocaine group. ns: non-significant.
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behavioral sensitization. Thus, an acute cocaine injection in 
naïve mice produced little changes in the endocannabinoid-
related proteins, although we detected an overall decrease in the 
ratios of NAPE-PLD/FAAH and DAGLα/MAGL. Even though the 
endocannabinoid-synthesizing enzymes displayed a trend to 
decrease, they were found to be unaltered in the present study. 
Previous studies with DAGL-deficient mice indicated that DAGLα 
is the major enzyme needed for retrograde synaptic 2-AG signal-
ing in the nervous system (Gao et al., 2010). On the other hand, 
acute cocaine administration has been reported to increase the 
endocannabinoid formation via the activation of dopaminergic 
D2 receptors (Giuffrida et al., 1999; Centonze et al., 2004).
Concerning repeated cocaine exposure, during cocaine-
conditioned locomotion we observed an increase in protein and 
gene expression of CB1 receptor in the PFC. In addition, cocaine 
priming after the repeated cocaine pretreatment enhanced the 
endocannabinoid-degrading profile, increasing FAAH and MAGL 
enzymes in the PFC, and the NAPE-PLD/FAAH, DAGLα/MAGL 
and DAGLβ/MAGL ratios were clearly reduced. CB1 receptor 
expression also increased after administration of cocaine prim-
ing injections. The upregulation of the CB1 receptor might be a 
compensatory mechanism to counteract the low availability of 
retrograde endocannabinoid inhibitory signals. Supporting this 
finding, a recent report by Orio and colleagues (2009) found that 
the anandamide and 2-AG release, as measured by microdialy-
sis, was reduced in rats that were self-administering cocaine. 
This finding was associated with enhanced expression of CB1 
receptors. In a previous study by our group (Rivera et al., 2013), 
we also demonstrated a similar finding in the hippocampus 
of Lewis rats self-administering cocaine. Although we did not 
measure the expression of the cannabinoid CB2 receptor in the 
present study, we cannot rule out a role for this receptor in the 
neuroadaptive responses to cocaine, as recently suggested (Xi 
et al., 2011; Aracil-Fernandez et al., 2012).
This combination of results in protein and gene expression 
is suggestive of a reduced availability of the endocannabinoids, 
and we consider that the repeated administration of cocaine 
could lead to a desensitization of dopaminergic D2 receptor-
driven endocannabinoid inhibitory signal by adapting the 
machinery needed for its production and degradation (Giuffrida 
et al., 1999; Centonze et al., 2004).
Increased Glutamatergic Signaling
In addition to the endocannabinoid changes, an increase in 
the gene expression of the glutamatergic signaling was also 
observed in these sensitized mice, mainly in synthesis enzymes 
and glutamate receptors. Glutamate, but not dopamine neu-
rotransmission, seems to be a primary mediator of cocaine-
induced behaviors associated with drug seeking (Cornish 
and Kalivas, 2000). The stimulation of glutamate receptors in 
the NAc augments the reinforcing effects of cocaine, and the 
increased glutamatergic neurotransmission may be involved 
in facilitating the relapse to cocaine-seeking behavior (Cornish 
et al., 1999). The activation of group I (mGluR1/5) metabotropic 
receptors resulted in an increase in the extracellular glutamate 
levels in the NAc (Swanson et al., 2001). Moreover, the stimula-
tion of mGluR5 in the PFC is sufficient to induce cocaine sensiti-
zation (Timmer and Steketee, 2012), whereas the administration 
of mGluR5 antagonists attenuated cocaine priming- and cue-
induced reinstatement of cocaine seeking (Platt et  al., 2008; 
Kumaresan et al., 2009). Previously, Chiamulera and colleagues 
(2001) showed that mGluR5-null mice do not display increased 
locomotor activity following cocaine treatment. Our present 
data are aligned with these findings, suggesting the induction 
of hyperactive glutamatergic signaling after repeated cocaine 
treatment. Thus, we found an increase in the expression of the 
glutamate-synthesizing enzymes LGA and KGA, which was 
associated with enhanced mRNA expression of mGluR3 and 
mGluR5, as well as that of the subunits of the AMPA receptors 
GluR1, GluR2, and GluR3. Of special relevance was the activation 
of mGluR5 expression, considering its relevant role in activat-
ing the endocannabinoid (2-AG-mediated) retrograde signaling 
(Gregg et al., 2012).
In summary, repeated cocaine administration modulates the 
expression of the endocannabinoid signaling machinery in the 
PFC. These changes are compatible with a situation in which the 
inhibitory actions of endocannabinoids on glutamatergic termi-
nals are affected. This scenario might contribute to the induc-
tion of behavioral sensitization, a process thought to be relevant 
for psychostimulant addiction.
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